2017
DOI: 10.1021/acs.nanolett.7b00814
|View full text |Cite
|
Sign up to set email alerts
|

A DNA Nanodevice That Loads and Releases a Cargo with Hemoglobin-Like Allosteric Control and Cooperativity

Abstract: Here we report the rational design of a synthetic molecular nanodevice that is directly inspired from hemoglobin, a highly evolved protein whose oxygen-carrying activity is finely regulated by a sophisticated network of control mechanisms. Inspired by the impressive performance of hemoglobin we have designed and engineered in vitro a synthetic DNA-based nanodevice containing up to four interacting binding sites that, like hemoglobin, can load and release a cargo over narrow concentration ranges, and whose affi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
26
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 33 publications
(26 citation statements)
references
References 51 publications
0
26
0
Order By: Relevance
“…Plaxco described how allostery and cooperativity may be leveraged to engineer a wide range of artificial optical, biochemical, and electrochemical biosensors. Among the examples used to illustrate the approach was the rational design and engineering of a synthetic DNA-based nanodevice containing up to four interacting binding sites that can load and release a cargo over narrow concentration ranges, and whose affinity could be finely controlled via both allosteric effectors and environmental cues such as pH and temperature (Mariottini et al, 2017). In another example, catalytic DNAzyme sequences (e.g., peroxidase-like DNAzymes) were combined with the consensus sequence recognized by specific transcription factors (either TATA binding protein or the microphthalmia-associated transcription factor).…”
Section: Rational Design Of Allosteric Systems and Identification Of mentioning
confidence: 99%
“…Plaxco described how allostery and cooperativity may be leveraged to engineer a wide range of artificial optical, biochemical, and electrochemical biosensors. Among the examples used to illustrate the approach was the rational design and engineering of a synthetic DNA-based nanodevice containing up to four interacting binding sites that can load and release a cargo over narrow concentration ranges, and whose affinity could be finely controlled via both allosteric effectors and environmental cues such as pH and temperature (Mariottini et al, 2017). In another example, catalytic DNAzyme sequences (e.g., peroxidase-like DNAzymes) were combined with the consensus sequence recognized by specific transcription factors (either TATA binding protein or the microphthalmia-associated transcription factor).…”
Section: Rational Design Of Allosteric Systems and Identification Of mentioning
confidence: 99%
“…Engineering complex self-regulation mechanisms using simple molecular assembly provides a quantitative and programmable chemical strategy to develop and optimize nanosystems with applications ranging from biosensing 49 to chemical computing 50,51 and drug delivery 52,53 . For example, current strategies to extend the dynamic range of sensors consist of combining two or multiple sensors with different affinities [54][55][56] .…”
Section: Discussionmentioning
confidence: 99%
“…Controlled Molecule Release : Inspired by the performance of hemoglobin, Mariottini synthesized the first hemoglobin‐like DNA‐based nanodevice with up to four interacting binding sites that realized ligand loading and releasing over narrow concentration ranges, and the ligand affinity could be controlled via both allosteric effectors and by environmental cues (i.e., temperature and pH) . Jeong et al prepared an electro‐responsive multilayer nanofilm on the surface of a chip‐electrode, which enabled controlled release of DNA strand responding to electrochemical inputs . The “sense‐and‐treat” localized the drug delivery system, in which the aptamer accompanied DNA tetrahedron to specifically destroy circulating tumor cells by synergetic chemotherapy with DOX and photodynamic therapy with generating toxic 1 O 2 .…”
Section: Biomedical Applicationsmentioning
confidence: 99%